Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 258

1.

Neurabin: a key factor in the specific neuroprotection mediated by Adenosine.

Cattabeni F.

Purinergic Signal. 2012 Dec;8(4):659-60. doi: 10.1007/s11302-012-9333-4. No abstract available.

2.

Distribution of interleukin-1 receptor complex at the synaptic membrane driven by interleukin-1β and NMDA stimulation.

Gardoni F, Boraso M, Zianni E, Corsini E, Galli CL, Cattabeni F, Marinovich M, Di Luca M, Viviani B.

J Neuroinflammation. 2011 Feb 11;8(1):14. doi: 10.1186/1742-2094-8-14.

3.

Synaptic localization and activity of ADAM10 regulate excitatory synapses through N-cadherin cleavage.

Malinverno M, Carta M, Epis R, Marcello E, Verpelli C, Cattabeni F, Sala C, Mulle C, Di Luca M, Gardoni F.

J Neurosci. 2010 Dec 1;30(48):16343-55. doi: 10.1523/JNEUROSCI.1984-10.2010.

4.

SAP97-mediated local trafficking is altered in Alzheimer disease patients' hippocampus.

Marcello E, Epis R, Saraceno C, Gardoni F, Borroni B, Cattabeni F, Padovani A, Di Luca M.

Neurobiol Aging. 2012 Feb;33(2):422.e1-10. doi: 10.1016/j.neurobiolaging.2010.09.015. Epub 2010 Oct 27.

5.

Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer's disease.

Epis R, Marcello E, Gardoni F, Vastagh C, Malinverno M, Balducci C, Colombo A, Borroni B, Vara H, Dell'Agli M, Cattabeni F, Giustetto M, Borsello T, Forloni G, Padovani A, Di Luca M.

Brain. 2010 Nov;133(11):3323-35. doi: 10.1093/brain/awq217. Epub 2010 Aug 30.

PMID:
20805102
6.

Decreased NR2B subunit synaptic levels cause impaired long-term potentiation but not long-term depression.

Gardoni F, Mauceri D, Malinverno M, Polli F, Costa C, Tozzi A, Siliquini S, Picconi B, Cattabeni F, Calabresi P, Di Luca M.

J Neurosci. 2009 Jan 21;29(3):669-77. doi: 10.1523/JNEUROSCI.3921-08.2009.

7.

Modulatory effect of acetyl-L-carnitine on amyloid precursor protein metabolism in hippocampal neurons.

Epis R, Marcello E, Gardoni F, Longhi A, Calvani M, Iannuccelli M, Cattabeni F, Canonico PL, Di Luca M.

Eur J Pharmacol. 2008 Nov 12;597(1-3):51-6. doi: 10.1016/j.ejphar.2008.09.001. Epub 2008 Sep 6.

PMID:
18801359
8.

Fatty acid profiles of blood lipids in a population group in Tibet: correlations with diet and environmental conditions.

Risé P, Marangoni F, Martiello A, Colombo C, Manzoni C, Marconi C, Cattabeni F, Galli C.

Asia Pac J Clin Nutr. 2008;17(1):80-5.

9.

Synapse-associated protein-97 mediates alpha-secretase ADAM10 trafficking and promotes its activity.

Marcello E, Gardoni F, Mauceri D, Romorini S, Jeromin A, Epis R, Borroni B, Cattabeni F, Sala C, Padovani A, Di Luca M.

J Neurosci. 2007 Feb 14;27(7):1682-91.

10.

Calcium-calmodulin-dependent protein kinase II phosphorylation modulates PSD-95 binding to NMDA receptors.

Gardoni F, Polli F, Cattabeni F, Di Luca M.

Eur J Neurosci. 2006 Nov;24(10):2694-704.

PMID:
17156196
11.

A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia.

Gardoni F, Picconi B, Ghiglieri V, Polli F, Bagetta V, Bernardi G, Cattabeni F, Di Luca M, Calabresi P.

J Neurosci. 2006 Mar 15;26(11):2914-22.

12.

Purines 2000: Third International Symposium on Nucleosides and Nucleotides. 9-13 July 2000, Madrid, Spain.

Cattabeni F, Williams M.

IDrugs. 2000 Oct;3(10):1182-4. No abstract available.

PMID:
16049838
13.

Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients.

Zimmermann M, Borroni B, Cattabeni F, Padovani A, Di Luca M.

Neurobiol Dis. 2005 Jun-Jul;19(1-2):237-42.

PMID:
15837579
14.

Ralfinamide. Newron Pharmaceuticals.

Cattabeni F.

IDrugs. 2004 Oct;7(10):935-9. No abstract available.

PMID:
15478019
15.

Platelets provide human tissue to unravel pathogenic mechanisms of Alzheimer disease.

Cattabeni F, Colciaghi F, Di Luca M.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 Aug;28(5):763-70. Review.

PMID:
15363602
16.

Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines.

Zimmermann M, Gardoni F, Marcello E, Colciaghi F, Borroni B, Padovani A, Cattabeni F, Di Luca M.

J Neurochem. 2004 Sep;90(6):1489-99.

17.

Amyloid precursor protein metabolism is regulated toward alpha-secretase pathway by Ginkgo biloba extracts.

Colciaghi F, Borroni B, Zimmermann M, Bellone C, Longhi A, Padovani A, Cattabeni F, Christen Y, Di Luca M.

Neurobiol Dis. 2004 Jul;16(2):454-60.

PMID:
15193301
18.

Calcium/calmodulin-dependent protein kinase II phosphorylation drives synapse-associated protein 97 into spines.

Mauceri D, Cattabeni F, Di Luca M, Gardoni F.

J Biol Chem. 2004 May 28;279(22):23813-21. Epub 2004 Mar 24.

19.

Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease.

Colciaghi F, Marcello E, Borroni B, Zimmermann M, Caltagirone C, Cattabeni F, Padovani A, Di Luca M.

Neurology. 2004 Feb 10;62(3):498-501.

PMID:
14872043
20.

Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: a 2-year follow-up study.

Borroni B, Colciaghi F, Caltagirone C, Rozzini L, Broglio L, Cattabeni F, Di Luca M, Padovani A.

Arch Neurol. 2003 Dec;60(12):1740-4.

PMID:
14676049
21.

Adenosine-induced cell death: evidence for receptor-mediated signalling.

Jacobson KA, Hoffmann C, Cattabeni F, Abbracchio MP.

Apoptosis. 1999 Jun;4(3):197-211.

PMID:
14634282
22.

Aberrant A2A receptor function in peripheral blood cells in Huntington's disease.

Varani K, Abbracchio MP, Cannella M, Cislaghi G, Giallonardo P, Mariotti C, Cattabriga E, Cattabeni F, Borea PA, Squitieri F, Cattaneo E.

FASEB J. 2003 Nov;17(14):2148-50. Epub 2003 Sep 4.

PMID:
12958155
23.

CaMKII-dependent phosphorylation regulates SAP97/NR2A interaction.

Gardoni F, Mauceri D, Fiorentini C, Bellone C, Missale C, Cattabeni F, Di Luca M.

J Biol Chem. 2003 Nov 7;278(45):44745-52. Epub 2003 Aug 21.

24.

High cholesterol affects platelet APP processing in controls and in AD patients.

Borroni B, Colciaghi F, Lenzi GL, Caimi L, Cattabeni F, Di Luca M, Padovani A.

Neurobiol Aging. 2003 Sep;24(5):631-6.

PMID:
12885570
25.

The NMDA receptor complex is altered in an animal model of human cerebral heterotopia.

Gardoni F, Pagliardini S, Setola V, Bassanini S, Cattabeni F, Battaglia G, Di Luca M.

J Neuropathol Exp Neurol. 2003 Jun;62(6):662-75.

PMID:
12834111
26.

Neurogenesis in cerebral heterotopia induced in rats by prenatal methylazoxymethanol treatment.

Battaglia G, Pagliardini S, Saglietti L, Cattabeni F, Di Luca M, Bassanini S, Setola V.

Cereb Cortex. 2003 Jul;13(7):736-48.

PMID:
12816889
27.

A key role for caspase-2 and caspase-3 in the apoptosis induced by 2-chloro-2'-deoxy-adenosine (cladribine) and 2-chloro-adenosine in human astrocytoma cells.

Ceruti S, Beltrami E, Matarrese P, Mazzola A, Cattabeni F, Malorni W, Abbracchio MP.

Mol Pharmacol. 2003 Jun;63(6):1437-47.

PMID:
12761355
28.

Long-lasting effects of neonatal dexamethasone treatment on spatial learning and hippocampal synaptic plasticity: involvement of the NMDA receptor complex.

Kamphuis PJ, Gardoni F, Kamal A, Croiset G, Bakker JM, Cattabeni F, Gispen WH, van Bel F, Di Luca M, Wiegant VM.

FASEB J. 2003 May;17(8):911-3. Epub 2003 Mar 5.

PMID:
12626441
29.

Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms.

Borroni B, Colciaghi F, Corsini P, Akkawi N, Rozzini L, Del Zotto E, Talarico G, Cattabeni F, Lenzi GL, Di Luca M, Padovani A.

Neurol Sci. 2002 Dec;23(5):207-10.

PMID:
12522675
30.

Altropane (Boston Life Science).

Cattabeni F.

Curr Opin Investig Drugs. 2002 Nov;3(11):1647-51. Review.

PMID:
12476968
31.

Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation.

Varani K, Laghi-Pasini F, Camurri A, Capecchi PL, Maccherini M, Diciolla F, Ceccatelli L, Lazzerini PE, Ulouglu C, Cattabeni F, Borea PA, Abbracchio MP.

FASEB J. 2003 Feb;17(2):280-2. Epub 2002 Dec 3.

PMID:
12475889
32.

Induction of COX-2 and reactive gliosis by P2Y receptors in rat cortical astrocytes is dependent on ERK1/2 but independent of calcium signalling.

Brambilla R, Neary JT, Cattabeni F, Cottini L, D'Ippolito G, Schiller PC, Abbracchio MP.

J Neurochem. 2002 Dec;83(6):1285-96.

33.

A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulation.

Trincavelli ML, Tuscano D, Marroni M, Falleni A, Gremigni V, Ceruti S, Abbracchio MP, Jacobson KA, Cattabeni F, Martini C.

Mol Pharmacol. 2002 Dec;62(6):1373-84.

34.

Synaptic plasticity in the diabetic brain: advanced aging?

Artola A, Kamal A, Ramakers GM, Gardoni F, Di Luca M, Biessels GJ, Cattabeni F, Gispen WH.

Prog Brain Res. 2002;138:305-14. Review. No abstract available.

PMID:
12432776
35.

Ginkgo biloba extract: from molecular mechanisms to the treatment of Alzhelmer's disease.

Zimmermann M, Colciaghi F, Cattabeni F, Di Luca M.

Cell Mol Biol (Noisy-le-grand). 2002 Sep;48(6):613-23. Review.

PMID:
12396071
36.

Lack of PSD-95 drives hippocampal neuronal cell death through activation of an alpha CaMKII transduction pathway.

Gardoni F, Bellone C, Viviani B, Marinovich M, Meli E, Pellegrini-Giampietro DE, Cattabeni F, Di Luca M.

Eur J Neurosci. 2002 Sep;16(5):777-86.

PMID:
12372013
37.

[alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients.

Colciaghi F, Borroni B, Pastorino L, Marcello E, Zimmermann M, Cattabeni F, Padovani A, Di Luca M.

Mol Med. 2002 Feb;8(2):67-74.

38.

ApoE genotype influences the biological effect of donepezil on APP metabolism in Alzheimer disease: evidence from a peripheral model.

Borroni B, Colciaghi F, Pastorino L, Archetti S, Corsini P, Cattabeni F, Di Luca M, Padovani A.

Eur Neuropsychopharmacol. 2002 Jun;12(3):195-200.

PMID:
12007670
39.

Effects of streptozotocin-diabetes on the hippocampal NMDA receptor complex in rats.

Gardoni F, Kamal A, Bellone C, Biessels GJ, Ramakers GM, Cattabeni F, Gispent WH, Di Luca M.

J Neurochem. 2002 Feb;80(3):438-47.

40.

Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease.

Padovani A, Borroni B, Colciaghi F, Pettenati C, Cottini E, Agosti C, Lenzi GL, Caltagirone C, Trabucchi M, Cattabeni F, Di Luca M.

Arch Neurol. 2002 Jan;59(1):71-5.

PMID:
11790233
41.

Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD.

Padovani A, Pastorino L, Borroni B, Colciaghi F, Rozzini L, Monastero R, Perez J, Pettenati C, Mussi M, Parrinello G, Cottini E, Lenzi GL, Trabucchi M, Cattabeni F, Di Luca M.

Neurology. 2001 Dec 26;57(12):2243-8.

PMID:
11756604
42.

Platelet amyloid precursor protein forms in AD: a peripheral diagnostic tool and a pharmacological target.

Padovani A, Borroni B, Colciaghi F, Pastorino L, Archetti S, Cottini E, Caimi L, Cattabeni F, Di Luca M.

Mech Ageing Dev. 2001 Nov;122(16):1997-2004. Review.

PMID:
11589917
43.

The A3 adenosine receptor induces cytoskeleton rearrangement in human astrocytoma cells via a specific action on Rho proteins.

Abbracchio MP, Camurri A, Ceruti S, Cattabeni F, Falzano L, Giammarioli AM, Jacobson KA, Trincavelli L, Martini C, Malorni W, Fiorentini C.

Ann N Y Acad Sci. 2001 Jun;939:63-73.

44.

Autoradiographic localization of [3H]thiocolchicoside binding sites in the rat brain and spinal cord.

Balduini W, De Angelis V, Mazzoni E, Depoortere H, Cattabeni F, Cimino M.

Neuropharmacology. 2001 Jun;40(8):1044-9.

PMID:
11406196
45.

Aberrant amplification of A(2A) receptor signaling in striatal cells expressing mutant huntingtin.

Varani K, Rigamonti D, Sipione S, Camurri A, Borea PA, Cattabeni F, Abbracchio MP, Cattaneo E.

FASEB J. 2001 May;15(7):1245-7. No abstract available.

PMID:
11344102
46.

NMDA receptor subunits are phosphorylated by activation of neurotrophin receptors in PSD of rat spinal cord.

Di Luca M, Gardoni F, Finardi A, Pagliardini S, Cattabeni F, Battaglia G, Missale C.

Neuroreport. 2001 May 8;12(6):1301-5.

PMID:
11338211
47.

Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetylcholinesterase inhibitor treatment.

Borroni B, Colciaghi F, Pastorino L, Pettenati C, Cottini E, Rozzini L, Monastero R, Lenzi GL, Cattabeni F, Di Luca M, Padovani A.

Arch Neurol. 2001 Mar;58(3):442-6.

PMID:
11255448
49.

Presenilin 2 mutation does not influence expression and concentration of APP forms in human platelets.

Pastorino L, Colciaghi F, Marcon G, Borroni B, Cottini E, Cattabeni F, Padovani A, Di Luca M.

Mol Med. 2000 Oct;6(10):816-24.

50.

Protein kinase C activation modulates alpha-calmodulin kinase II binding to NR2A subunit of N-methyl-D-aspartate receptor complex.

Gardoni F, Bellone C, Cattabeni F, Di Luca M.

J Biol Chem. 2001 Mar 9;276(10):7609-13. Epub 2000 Dec 4.

Supplemental Content

Loading ...
Support Center